SFAC. 10-Q/A . PR's: New Investment. Share Buy back. Video.

(5 hours ago) SafeCode Drug Technologies Receives Investment From Biomedix Ltd

Biomedix is an Israel-based, publicly-traded Life Science (BMDX) has agreed to fund and purchase SAFC shares at 0.15 cents per share . Biomedix currently holds $200,000 USD worth of SafeCode Drug Technologies shares on its books.

1/2/13 SafeCode Drug Technologies Corporation Announce Share Buy Back Program

SafeCode Drug Technologies Corp is authorized to repurchase up to 1 million of its outstanding shares of common stock at a price up to $0.20 per share on the open market